Adams William A. 4/A

What Happened

• William A. Adams, a director of National Healthcare Corp. (NHC), was awarded 7,500 derivative shares (reported as an acquisition/award) on 2026-05-07. The Form 4/A corrects the acquisition price to $171.42 per share (previously and incorrectly reported as $0.00), implying a grant value of approximately $1,285,650.
• This is a grant of derivative securities (an award), not an open-market purchase or sale. There is no indication in this filing that any shares were sold or that options were exercised immediately.

Key Details

• Transaction date: 2026-05-07; Amended Form 4 filed: 2026-05-08.
• Corrected acquisition price: $171.42 per share (correction noted in footnote F1).
• Number of derivative securities awarded: 7,500; approximate total value: $1,285,650.
• Shares owned after transaction: not specified in the information provided in this summary (check the full Form 4/A for ownership columns).
• Footnote: F1 states the original Form 4 incorrectly showed a $0.00 price; this Form 4/A corrects the price to the 5/7/2026 closing price.
• Filing status: this is an amended filing to correct the previously reported price.

Context

• This report documents a grant of derivative securities (an award). Grants are compensation events and do not necessarily reflect a director buying or selling stock in the open market.
• For retail investors, grants can indicate executive/board compensation alignment with shareholders but are not direct buy/sell signals. Check vesting terms or the company’s proxy for further details on restrictions and potential future dilution.